- Book
- May 2012
- 528 Pages
- Book
- May 2024
- 464 Pages
- Book
- September 2024
- 304 Pages
- Book
- May 2021
- 832 Pages
- Book
- September 2020
- 608 Pages
- Book
- September 2020
- 1136 Pages
- Book
- August 2010
- 656 Pages
- Book
- August 2023
Global
The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases.
Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field.
The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more